 | • レポートコード：GIR-2104Z07935 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、過敏性腸症候群治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。過敏性腸症候群治療の種類別市場規模（便秘過敏性腸症候群、下痢過敏性腸症候群、便秘・下痢過敏性腸症候群）、用途別市場規模（病院、診療所、在宅医療設定）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・過敏性腸症候群治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Bausch Health、Sucampo Pharmaceuticals、Abbott Laboratories、Lexicon Pharmaceuticals、Salix Pharmaceuticals、Ironwood Pharmaceuticals、GlaxoSmithKline、Allergan ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：便秘過敏性腸症候群、下痢過敏性腸症候群、便秘・下痢過敏性腸症候群 ・用途別分析2016年-2026年：病院、診療所、在宅医療設定 ・過敏性腸症候群治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・過敏性腸症候群治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・過敏性腸症候群治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・過敏性腸症候群治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・過敏性腸症候群治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Irritable Bowel Syndrome Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Irritable Bowel Syndrome Treatment size is estimated to be USD 2253.6 million in 2025 from USD 1918 million in 2019, with a change XX% between 2019 and 2020. The global Irritable Bowel Syndrome Treatment market size is expected to grow at a CAGR of 4.1% for the next five years.
Market segmentation
Irritable Bowel Syndrome Treatment market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Irritable Bowel Syndrome with Constipation
Irritable Bowel Syndrome with Diarrhea
Irritable Bowel Syndrome with alternating Constipationand Diarrhea
Market segment by Application, can be divided into
Hospitals
Clinics
Homecare settings
Market segment by players, this report covers
Bausch Health
Sucampo Pharmaceuticals
Abbott Laboratories
Lexicon Pharmaceuticals
Salix Pharmaceuticals
Ironwood Pharmaceuticals
GlaxoSmithKline
Allergan
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Irritable Bowel Syndrome Treatment
1.2 Classification of Irritable Bowel Syndrome Treatment by Type
1.2.1 Overview: Global Irritable Bowel Syndrome Treatment Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Irritable Bowel Syndrome Treatment Revenue Market Share by Type in 2020
1.2.3 Irritable Bowel Syndrome with Constipation
1.2.4 Irritable Bowel Syndrome with Diarrhea
1.2.5 Irritable Bowel Syndrome with alternating Constipationand Diarrhea
1.3 Global Irritable Bowel Syndrome Treatment Market by Application
1.3.1 Overview: Global Irritable Bowel Syndrome Treatment Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Homecare settings
1.4 Global Irritable Bowel Syndrome Treatment Market Size & Forecast
1.5 Global Irritable Bowel Syndrome Treatment Market Size and Forecast by Region
1.5.1 Global Irritable Bowel Syndrome Treatment Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Irritable Bowel Syndrome Treatment Market Size by Region, (2016-2021)
1.5.3 North America Irritable Bowel Syndrome Treatment Market Size and Prospect (2016-2026)
1.5.4 Europe Irritable Bowel Syndrome Treatment Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Irritable Bowel Syndrome Treatment Market Size and Prospect (2016-2026)
1.5.6 South America Irritable Bowel Syndrome Treatment Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Irritable Bowel Syndrome Treatment Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Irritable Bowel Syndrome Treatment Market Drivers
1.6.2 Irritable Bowel Syndrome Treatment Market Restraints
1.6.3 Irritable Bowel Syndrome Treatment Trends Analysis
2 Company Profiles
2.1 Bausch Health
2.1.1 Bausch Health Details
2.1.2 Bausch Health Major Business
2.1.3 Bausch Health Irritable Bowel Syndrome Treatment Product and Solutions
2.1.4 Bausch Health Irritable Bowel Syndrome Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Bausch Health Recent Developments and Future Plans
2.2 Sucampo Pharmaceuticals
2.2.1 Sucampo Pharmaceuticals Details
2.2.2 Sucampo Pharmaceuticals Major Business
2.2.3 Sucampo Pharmaceuticals Irritable Bowel Syndrome Treatment Product and Solutions
2.2.4 Sucampo Pharmaceuticals Irritable Bowel Syndrome Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Sucampo Pharmaceuticals Recent Developments and Future Plans
2.3 Abbott Laboratories
2.3.1 Abbott Laboratories Details
2.3.2 Abbott Laboratories Major Business
2.3.3 Abbott Laboratories Irritable Bowel Syndrome Treatment Product and Solutions
2.3.4 Abbott Laboratories Irritable Bowel Syndrome Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Abbott Laboratories Recent Developments and Future Plans
2.4 Lexicon Pharmaceuticals
2.4.1 Lexicon Pharmaceuticals Details
2.4.2 Lexicon Pharmaceuticals Major Business
2.4.3 Lexicon Pharmaceuticals Irritable Bowel Syndrome Treatment Product and Solutions
2.4.4 Lexicon Pharmaceuticals Irritable Bowel Syndrome Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Lexicon Pharmaceuticals Recent Developments and Future Plans
2.5 Salix Pharmaceuticals
2.5.1 Salix Pharmaceuticals Details
2.5.2 Salix Pharmaceuticals Major Business
2.5.3 Salix Pharmaceuticals Irritable Bowel Syndrome Treatment Product and Solutions
2.5.4 Salix Pharmaceuticals Irritable Bowel Syndrome Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Salix Pharmaceuticals Recent Developments and Future Plans
2.6 Ironwood Pharmaceuticals
2.6.1 Ironwood Pharmaceuticals Details
2.6.2 Ironwood Pharmaceuticals Major Business
2.6.3 Ironwood Pharmaceuticals Irritable Bowel Syndrome Treatment Product and Solutions
2.6.4 Ironwood Pharmaceuticals Irritable Bowel Syndrome Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Ironwood Pharmaceuticals Recent Developments and Future Plans
2.7 GlaxoSmithKline
2.7.1 GlaxoSmithKline Details
2.7.2 GlaxoSmithKline Major Business
2.7.3 GlaxoSmithKline Irritable Bowel Syndrome Treatment Product and Solutions
2.7.4 GlaxoSmithKline Irritable Bowel Syndrome Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 GlaxoSmithKline Recent Developments and Future Plans
2.8 Allergan
2.8.1 Allergan Details
2.8.2 Allergan Major Business
2.8.3 Allergan Irritable Bowel Syndrome Treatment Product and Solutions
2.8.4 Allergan Irritable Bowel Syndrome Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Allergan Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Irritable Bowel Syndrome Treatment Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Irritable Bowel Syndrome Treatment Players Market Share
3.2.2 Top 10 Irritable Bowel Syndrome Treatment Players Market Share
3.2.3 Market Competition Trend
3.3 Irritable Bowel Syndrome Treatment Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Irritable Bowel Syndrome Treatment Revenue and Market Share by Type (2016-2021)
4.2 Global Irritable Bowel Syndrome Treatment Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Irritable Bowel Syndrome Treatment Revenue Market Share by Application (2016-2021)
5.2 Irritable Bowel Syndrome Treatment Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Irritable Bowel Syndrome Treatment Revenue by Type (2016-2026)
6.2 North America Irritable Bowel Syndrome Treatment Revenue by Application (2016-2026)
6.3 North America Irritable Bowel Syndrome Treatment Market Size by Country
6.3.1 North America Irritable Bowel Syndrome Treatment Revenue by Country (2016-2026)
6.3.2 United States Irritable Bowel Syndrome Treatment Market Size and Forecast (2016-2026)
6.3.3 Canada Irritable Bowel Syndrome Treatment Market Size and Forecast (2016-2026)
6.3.4 Mexico Irritable Bowel Syndrome Treatment Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Irritable Bowel Syndrome Treatment Revenue by Type (2016-2026)
7.2 Europe Irritable Bowel Syndrome Treatment Revenue by Application (2016-2026)
7.3 Europe Irritable Bowel Syndrome Treatment Market Size by Country
7.3.1 Europe Irritable Bowel Syndrome Treatment Revenue by Country (2016-2026)
7.3.2 Germany Irritable Bowel Syndrome Treatment Market Size and Forecast (2016-2026)
7.3.3 France Irritable Bowel Syndrome Treatment Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Irritable Bowel Syndrome Treatment Market Size and Forecast (2016-2026)
7.3.5 Russia Irritable Bowel Syndrome Treatment Market Size and Forecast (2016-2026)
7.3.6 Italy Irritable Bowel Syndrome Treatment Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Irritable Bowel Syndrome Treatment Revenue by Type (2016-2026)
8.2 Asia-Pacific Irritable Bowel Syndrome Treatment Revenue by Application (2016-2026)
8.3 Asia-Pacific Irritable Bowel Syndrome Treatment Market Size by Region
8.3.1 Asia-Pacific Irritable Bowel Syndrome Treatment Revenue by Region (2016-2026)
8.3.2 China Irritable Bowel Syndrome Treatment Market Size and Forecast (2016-2026)
8.3.3 Japan Irritable Bowel Syndrome Treatment Market Size and Forecast (2016-2026)
8.3.4 South Korea Irritable Bowel Syndrome Treatment Market Size and Forecast (2016-2026)
8.3.5 India Irritable Bowel Syndrome Treatment Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Irritable Bowel Syndrome Treatment Market Size and Forecast (2016-2026)
8.3.7 Australia Irritable Bowel Syndrome Treatment Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Irritable Bowel Syndrome Treatment Revenue by Type (2016-2026)
9.2 South America Irritable Bowel Syndrome Treatment Revenue by Application (2016-2026)
9.3 South America Irritable Bowel Syndrome Treatment Market Size by Country
9.3.1 South America Irritable Bowel Syndrome Treatment Revenue by Country (2016-2026)
9.3.2 Brazil Irritable Bowel Syndrome Treatment Market Size and Forecast (2016-2026)
9.3.3 Argentina Irritable Bowel Syndrome Treatment Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Irritable Bowel Syndrome Treatment Revenue by Type (2016-2026)
10.2 Middle East & Africa Irritable Bowel Syndrome Treatment Revenue by Application (2016-2026)
10.3 Middle East & Africa Irritable Bowel Syndrome Treatment Market Size by Country
10.3.1 Middle East & Africa Irritable Bowel Syndrome Treatment Revenue by Country (2016-2026)
10.3.2 Turkey Irritable Bowel Syndrome Treatment Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Irritable Bowel Syndrome Treatment Market Size and Forecast (2016-2026)
10.3.4 UAE Irritable Bowel Syndrome Treatment Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Irritable Bowel Syndrome Treatment Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Irritable Bowel Syndrome Treatment Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Irritable Bowel Syndrome Treatment Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Irritable Bowel Syndrome Treatment Revenue (USD Million) by Region (2016-2021)
Table 5. Global Irritable Bowel Syndrome Treatment Revenue Market Share by Region (2021-2026)
Table 6. Bausch Health Corporate Information, Head Office, and Major Competitors
Table 7. Bausch Health Major Business
Table 8. Bausch Health Irritable Bowel Syndrome Treatment Product and Solutions
Table 9. Bausch Health Irritable Bowel Syndrome Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Sucampo Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 11. Sucampo Pharmaceuticals Major Business
Table 12. Sucampo Pharmaceuticals Irritable Bowel Syndrome Treatment Product and Solutions
Table 13. Sucampo Pharmaceuticals Irritable Bowel Syndrome Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
Table 15. Abbott Laboratories Major Business
Table 16. Abbott Laboratories Irritable Bowel Syndrome Treatment Product and Solutions
Table 17. Abbott Laboratories Irritable Bowel Syndrome Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Lexicon Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 19. Lexicon Pharmaceuticals Major Business
Table 20. Lexicon Pharmaceuticals Irritable Bowel Syndrome Treatment Product and Solutions
Table 21. Lexicon Pharmaceuticals Irritable Bowel Syndrome Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Salix Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 23. Salix Pharmaceuticals Major Business
Table 24. Salix Pharmaceuticals Irritable Bowel Syndrome Treatment Product and Solutions
Table 25. Salix Pharmaceuticals Irritable Bowel Syndrome Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Ironwood Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 27. Ironwood Pharmaceuticals Major Business
Table 28. Ironwood Pharmaceuticals Irritable Bowel Syndrome Treatment Product and Solutions
Table 29. Ironwood Pharmaceuticals Irritable Bowel Syndrome Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 31. GlaxoSmithKline Major Business
Table 32. GlaxoSmithKline Irritable Bowel Syndrome Treatment Product and Solutions
Table 33. GlaxoSmithKline Irritable Bowel Syndrome Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Allergan Corporate Information, Head Office, and Major Competitors
Table 35. Allergan Major Business
Table 36. Allergan Irritable Bowel Syndrome Treatment Product and Solutions
Table 37. Allergan Irritable Bowel Syndrome Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Global Irritable Bowel Syndrome Treatment Revenue (USD Million) by Players (2019-2021)
Table 39. Global Irritable Bowel Syndrome Treatment Revenue Share by Players (2019-2021)
Table 40. Breakdown of Irritable Bowel Syndrome Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 41. Irritable Bowel Syndrome Treatment Players Head Office, Products and Services Provided
Table 42. Irritable Bowel Syndrome Treatment Mergers & Acquisitions in the Past Five Years
Table 43. Irritable Bowel Syndrome Treatment New Entrants and Expansion Plans
Table 44. Global Irritable Bowel Syndrome Treatment Revenue (USD Million) by Type (2016-2021)
Table 45. Global Irritable Bowel Syndrome Treatment Revenue Share by Type (2016-2021)
Table 46. Global Irritable Bowel Syndrome Treatment Revenue Forecast by Type (2021-2026)
Table 47. Global Irritable Bowel Syndrome Treatment Revenue by Application (2016-2021)
Table 48. Global Irritable Bowel Syndrome Treatment Revenue Forecast by Application (2021-2026)
Table 49. North America Irritable Bowel Syndrome Treatment Revenue by Type (2016-2021) & (USD Million)
Table 50. North America Irritable Bowel Syndrome Treatment Revenue by Type (2021-2026) & (USD Million)
Table 51. North America Irritable Bowel Syndrome Treatment Revenue by Application (2016-2021) & (USD Million)
Table 52. North America Irritable Bowel Syndrome Treatment Revenue by Application (2021-2026) & (USD Million)
Table 53. North America Irritable Bowel Syndrome Treatment Revenue by Country (2016-2021) & (USD Million)
Table 54. North America Irritable Bowel Syndrome Treatment Revenue by Country (2021-2026) & (USD Million)
Table 55. Europe Irritable Bowel Syndrome Treatment Revenue by Type (2016-2021) & (USD Million)
Table 56. Europe Irritable Bowel Syndrome Treatment Revenue by Type (2021-2026) & (USD Million)
Table 57. Europe Irritable Bowel Syndrome Treatment Revenue by Application (2016-2021) & (USD Million)
Table 58. Europe Irritable Bowel Syndrome Treatment Revenue by Application (2021-2026) & (USD Million)
Table 59. Europe Irritable Bowel Syndrome Treatment Revenue by Country (2016-2021) & (USD Million)
Table 60. Europe Irritable Bowel Syndrome Treatment Revenue by Country (2021-2026) & (USD Million)
Table 61. Asia-Pacific Irritable Bowel Syndrome Treatment Revenue by Type (2016-2021) & (USD Million)
Table 62. Asia-Pacific Irritable Bowel Syndrome Treatment Revenue by Type (2021-2026) & (USD Million)
Table 63. Asia-Pacific Irritable Bowel Syndrome Treatment Revenue by Application (2016-2021) & (USD Million)
Table 64. Asia-Pacific Irritable Bowel Syndrome Treatment Revenue by Application (2021-2026) & (USD Million)
Table 65. Asia-Pacific Irritable Bowel Syndrome Treatment Revenue by Region (2016-2021) & (USD Million)
Table 66. Asia-Pacific Irritable Bowel Syndrome Treatment Revenue by Region (2021-2026) & (USD Million)
Table 67. South America Irritable Bowel Syndrome Treatment Revenue by Type (2016-2021) & (USD Million)
Table 68. South America Irritable Bowel Syndrome Treatment Revenue by Type (2021-2026) & (USD Million)
Table 69. South America Irritable Bowel Syndrome Treatment Revenue by Application (2016-2021) & (USD Million)
Table 70. South America Irritable Bowel Syndrome Treatment Revenue by Application (2021-2026) & (USD Million)
Table 71. South America Irritable Bowel Syndrome Treatment Revenue by Country (2016-2021) & (USD Million)
Table 72. South America Irritable Bowel Syndrome Treatment Revenue by Country (2021-2026) & (USD Million)
Table 73. Middle East & Africa Irritable Bowel Syndrome Treatment Revenue by Type (2016-2021) & (USD Million)
Table 74. Middle East & Africa Irritable Bowel Syndrome Treatment Revenue by Type (2021-2026) & (USD Million)
Table 75. Middle East & Africa Irritable Bowel Syndrome Treatment Revenue by Application (2016-2021) & (USD Million)
Table 76. Middle East & Africa Irritable Bowel Syndrome Treatment Revenue by Application (2021-2026) & (USD Million)
Table 77. Middle East & Africa Irritable Bowel Syndrome Treatment Revenue by Country (2016-2021) & (USD Million)
Table 78. Middle East & Africa Irritable Bowel Syndrome Treatment Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Irritable Bowel Syndrome Treatment Picture
Figure 2. Global Irritable Bowel Syndrome Treatment Revenue Market Share by Type in 2020
Figure 3. Irritable Bowel Syndrome with Constipation
Figure 4. Irritable Bowel Syndrome with Diarrhea
Figure 5. Irritable Bowel Syndrome with alternating Constipationand Diarrhea
Figure 6. Irritable Bowel Syndrome Treatment Revenue Market Share by Application in 2020
Figure 7. Hospitals Picture
Figure 8. Clinics Picture
Figure 9. Homecare settings Picture
Figure 10. Global Irritable Bowel Syndrome Treatment Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Irritable Bowel Syndrome Treatment Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Irritable Bowel Syndrome Treatment Revenue Market Share by Region (2016-2026)
Figure 13. Global Irritable Bowel Syndrome Treatment Revenue Market Share by Region in 2020
Figure 14. North America Irritable Bowel Syndrome Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Irritable Bowel Syndrome Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Irritable Bowel Syndrome Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Irritable Bowel Syndrome Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Irritable Bowel Syndrome Treatment Market Drivers
Figure 19. Irritable Bowel Syndrome Treatment Market Restraints
Figure 20. Irritable Bowel Syndrome Treatment Market Trends
Figure 21. Bausch Health Recent Developments and Future Plans
Figure 22. Sucampo Pharmaceuticals Recent Developments and Future Plans
Figure 23. Abbott Laboratories Recent Developments and Future Plans
Figure 24. Lexicon Pharmaceuticals Recent Developments and Future Plans
Figure 25. Salix Pharmaceuticals Recent Developments and Future Plans
Figure 26. Ironwood Pharmaceuticals Recent Developments and Future Plans
Figure 27. GlaxoSmithKline Recent Developments and Future Plans
Figure 28. Allergan Recent Developments and Future Plans
Figure 30. Global Irritable Bowel Syndrome Treatment Revenue Share by Players in 2020
Figure 31. Irritable Bowel Syndrome Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 32. Global Top 3 Players Irritable Bowel Syndrome Treatment Revenue Market Share in 2020
Figure 33. Global Top 10 Players Irritable Bowel Syndrome Treatment Revenue Market Share in 2020
Figure 34. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 35. Global Irritable Bowel Syndrome Treatment Revenue Share by Type in 2020
Figure 36. Global Irritable Bowel Syndrome Treatment Market Share Forecast by Type (2021-2026)
Figure 37. Global Irritable Bowel Syndrome Treatment Revenue Share by Application in 2020
Figure 38. Global Irritable Bowel Syndrome Treatment Market Share Forecast by Application (2021-2026)
Figure 39. North America Irritable Bowel Syndrome Treatment Sales Market Share by Type (2016-2026)
Figure 40. North America Irritable Bowel Syndrome Treatment Sales Market Share by Application (2016-2026)
Figure 41. North America Irritable Bowel Syndrome Treatment Revenue Market Share by Country (2016-2026)
Figure 42. United States Irritable Bowel Syndrome Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Canada Irritable Bowel Syndrome Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Mexico Irritable Bowel Syndrome Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Europe Irritable Bowel Syndrome Treatment Sales Market Share by Type (2016-2026)
Figure 46. Europe Irritable Bowel Syndrome Treatment Sales Market Share by Application (2016-2026)
Figure 47. Europe Irritable Bowel Syndrome Treatment Revenue Market Share by Country (2016-2026)
Figure 48. Germany Irritable Bowel Syndrome Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. France Irritable Bowel Syndrome Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. United Kingdom Irritable Bowel Syndrome Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Russia Irritable Bowel Syndrome Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Italy Irritable Bowel Syndrome Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Asia-Pacific Irritable Bowel Syndrome Treatment Sales Market Share by Type (2016-2026)
Figure 54. Asia-Pacific Irritable Bowel Syndrome Treatment Sales Market Share by Application (2016-2026)
Figure 55. Asia-Pacific Irritable Bowel Syndrome Treatment Revenue Market Share by Region (2016-2026)
Figure 56. China Irritable Bowel Syndrome Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Japan Irritable Bowel Syndrome Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. South Korea Irritable Bowel Syndrome Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. India Irritable Bowel Syndrome Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Southeast Asia Irritable Bowel Syndrome Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Australia Irritable Bowel Syndrome Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South America Irritable Bowel Syndrome Treatment Sales Market Share by Type (2016-2026)
Figure 63. South America Irritable Bowel Syndrome Treatment Sales Market Share by Application (2016-2026)
Figure 64. South America Irritable Bowel Syndrome Treatment Revenue Market Share by Country (2016-2026)
Figure 65. Brazil Irritable Bowel Syndrome Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Argentina Irritable Bowel Syndrome Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Middle East and Africa Irritable Bowel Syndrome Treatment Sales Market Share by Type (2016-2026)
Figure 68. Middle East and Africa Irritable Bowel Syndrome Treatment Sales Market Share by Application (2016-2026)
Figure 69. Middle East and Africa Irritable Bowel Syndrome Treatment Revenue Market Share by Country (2016-2026)
Figure 70. Turkey Irritable Bowel Syndrome Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Saudi Arabia Irritable Bowel Syndrome Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. UAE Irritable Bowel Syndrome Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Methodology
Figure 74. Research Process and Data Source
世界の過敏性腸症候群治療市場規模・現状・予測（2021年-2027年） Irritable bowel syndrome is a functional gastrointestinal disorder of gut that may be characterized by colon muscle contractions. Irritable bowel syndrome is a common disorder. There is no complete cure for the irritable bowel syndrome. Medicines used in irritable bowel syndrome are effective in dec…- 世界の過敏性腸症候群治療市場規模・現状・予測（2021年-2027年） Irritable bowel syndrome is a functional gastrointestinal disorder of gut that may be characterized by colon muscle contractions. Irritable bowel syndrome is a common disorder. There is no complete cure for the irritable bowel syndrome. Medicines used in irritable bowel syndrome are effective in dec…
- 世界の短腸症候群（SBS）市場規模・現状・予測（2021年-2027年） Short bowel syndrome (SBS) is a metabolic disorder occurs when the portion of the small intestine is not functioning or removed through surgery due to digestive illness. SBS is caused by lack of function of the small intestine. This results in malabsorption, diarrhea, steatorrhea, fluid and electrol…
- 世界の短腸症候群市場規模・現状・予測（2021年-2027年） Short bowel syndrome (SBS) is an intestinal disorder associated with malabsorption due to the lack of functional intestine. SBS can be congenital or an acquired condition which can be observed in patients in whom nearly half of the small intestine has been removed due to underlying disease condition…
- 世界の炎症性腸疾患（IBD）治療市場規模・現状・予測（2021年-2027年） Inflammatory bowel disease is a group of medical indication that causes chronic inflammation in the gastrointestinal tract. The inflammatory bowel disease mainly comprises of Ulcerative colitis and Crohn’s disease. The ulcerative colitis primarily affects the large intestine and anus and it causes t…